202 related articles for article (PubMed ID: 36546480)
1. Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation.
Biggs CM; Cordeiro-Santanach A; Prykhozhij SV; Deveau AP; Lin Y; Del Bel KL; Orben F; Ragotte RJ; Saferali A; Mostafavi S; Dinh L; Dai D; Weinacht KG; Dobbs K; Ott de Bruin L; Sharma M; Tsai K; Priatel JJ; Schreiber RA; Rozmus J; Hosking MC; Shopsowitz KE; McKinnon ML; Vercauteren S; Seear M; Notarangelo LD; Lynn FC; Berman JN; Turvey SE
JCI Insight; 2022 Dec; 7(24):. PubMed ID: 36546480
[TBL] [Abstract][Full Text] [Related]
2. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.
Baris S; Benamar M; Chen Q; Catak MC; Martínez-Blanco M; Wang M; Fong J; Massaad MJ; Sefer AP; Kara A; Babayeva R; Eltan SB; Yucelten AD; Bozkurtlar E; Cinel L; Karakoc-Aydiner E; Zheng Y; Wu H; Ozen A; Schmitz-Abe K; Chatila TA
J Allergy Clin Immunol; 2023 Jul; 152(1):182-194.e7. PubMed ID: 36758835
[TBL] [Abstract][Full Text] [Related]
3. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.
;
Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of JAK1-associated inflammatory disease.
Fayand A; Hentgen V; Posseme C; Lacout C; Picard C; Moguelet P; Cescato M; Sbeih N; Moreau TRJ; Zhu YYJ; Charuel JL; Corneau A; Deibener-Kaminsky J; Dupuy S; Fusaro M; Hoareau B; Hovnanian A; Langlois V; Le Corre L; Maciel TT; Miskinyte S; Miyara M; Moulinet T; Perret M; Schuhmacher MH; Rignault-Bricard R; Viel S; Vinit A; Soria A; Duffy D; Launay JM; Callebert J; Herbeuval JP; Rodero MP; Georgin-Lavialle S
J Allergy Clin Immunol; 2023 Oct; 152(4):972-983. PubMed ID: 37343845
[TBL] [Abstract][Full Text] [Related]
5. Atopy as Immune Dysregulation: Offender Genes and Targets.
Vaseghi-Shanjani M; Snow AL; Margolis DJ; Latrous M; Milner JD; Turvey SE; Biggs CM
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1737-1756. PubMed ID: 35680527
[TBL] [Abstract][Full Text] [Related]
6. Integrated genetic and epigenetic analyses uncover MSI2 association with allergic inflammation.
Kim KW; Park SC; Cho HJ; Jang H; Park J; Shim HS; Kim EG; Kim MN; Hong JY; Kim YH; Lee S; Weiss ST; Kim CH; Won S; Sohn MH
J Allergy Clin Immunol; 2021 Apr; 147(4):1453-1463. PubMed ID: 32795589
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor defects in inborn errors of immunity with atopy.
Vaseghi-Shanjani M; Yousefi P; Sharma M; Samra S; Sifuentes E; Turvey SE; Biggs CM
Front Allergy; 2023; 4():1237852. PubMed ID: 37727514
[TBL] [Abstract][Full Text] [Related]
8. Inborn errors of immunity manifesting as atopic disorders.
Vaseghi-Shanjani M; Smith KL; Sara RJ; Modi BP; Branch A; Sharma M; Lu HY; James EL; Hildebrand KJ; Biggs CM; Turvey SE
J Allergy Clin Immunol; 2021 Nov; 148(5):1130-1139. PubMed ID: 34428518
[TBL] [Abstract][Full Text] [Related]
9. Sensory neurons promote immune homeostasis in the lung.
Tamari M; Del Bel KL; Ver Heul AM; Zamidar L; Orimo K; Hoshi M; Trier AM; Yano H; Yang TL; Biggs CM; Motomura K; Shibuya R; Yu CD; Xie Z; Iriki H; Wang Z; Auyeung K; Damle G; Demircioglu D; Gregory JK; Hasson D; Dai J; Chang RB; Morita H; Matsumoto K; Jain S; Van Dyken S; Milner JD; Bogunovic D; Hu H; Artis D; Turvey SE; Kim BS
Cell; 2024 Jan; 187(1):44-61.e17. PubMed ID: 38134932
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
[TBL] [Abstract][Full Text] [Related]
11. Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.
Gruber CN; Calis JJA; Buta S; Evrony G; Martin JC; Uhl SA; Caron R; Jarchin L; Dunkin D; Phelps R; Webb BD; Saland JM; Merad M; Orange JS; Mace EM; Rosenberg BR; Gelb BD; Bogunovic D
Immunity; 2020 Sep; 53(3):672-684.e11. PubMed ID: 32750333
[TBL] [Abstract][Full Text] [Related]
12. Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma.
Sada M; Watanabe M; Inui T; Nakamoto K; Hirata A; Nakamura M; Honda K; Saraya T; Kurai D; Kimura H; Ishii H; Takizawa H
Immun Inflamm Dis; 2021 Jun; 9(2):363-373. PubMed ID: 33534941
[TBL] [Abstract][Full Text] [Related]
13. ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon.
Hornakova T; Chiaretti S; Lemaire MM; Foà R; Ben Abdelali R; Asnafi V; Tartaglia M; Renauld JC; Knoops L
Blood; 2010 Apr; 115(16):3287-95. PubMed ID: 20167706
[TBL] [Abstract][Full Text] [Related]
14. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice.
Lin W; Truong N; Grossman WJ; Haribhai D; Williams CB; Wang J; Martín MG; Chatila TA
J Allergy Clin Immunol; 2005 Nov; 116(5):1106-15. PubMed ID: 16275384
[TBL] [Abstract][Full Text] [Related]
15. Germline STAT6 gain-of-function variants cause severe allergy.
Yamashita M; Morio T
J Allergy Clin Immunol; 2023 May; 151(5):1252-1254. PubMed ID: 36958638
[No Abstract] [Full Text] [Related]
16. JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
Klaeschen AS; Nümm TJ; Herrmann N; Leib N; Maintz L; Sakai T; Wenzel J; Bieber T
J Allergy Clin Immunol; 2021 Jun; 147(6):2202-2212.e8. PubMed ID: 33338537
[TBL] [Abstract][Full Text] [Related]
17. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation.
Moriya K; Suzuki T; Uchida N; Nakano T; Katayama S; Irie M; Rikiishi T; Niizuma H; Okada S; Imai K; Sasahara Y; Kure S
Int J Hematol; 2020 Aug; 112(2):258-262. PubMed ID: 32180118
[TBL] [Abstract][Full Text] [Related]
18. IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1/microRNA-155 axis.
Chang J; Zhou B; Wei Z; Luo Y
J Transl Med; 2022 May; 20(1):207. PubMed ID: 35545774
[TBL] [Abstract][Full Text] [Related]
19. Allergic Inflammation Leads to Neuropathic Pain via Glial Cell Activation.
Yamasaki R; Fujii T; Wang B; Masaki K; Kido MA; Yoshida M; Matsushita T; Kira JI
J Neurosci; 2016 Nov; 36(47):11929-11945. PubMed ID: 27881779
[TBL] [Abstract][Full Text] [Related]
20. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
